University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 1 of 13
Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors
NCT07390045
Reducing Crises and Suicide Within the Idaho Army National Guard
NCT07032636
BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber
NCT07430735
The Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
NCT07092540
Facilitating Lactation Through Optimized Workflows - Evaluating the Efficiency of Pumping Protocols and Cellular Mechanisms of Milk Production
NCT07260968
Tele-Savvy for Latino Caregivers
NCT07290387
Thrive Person-Centered Planning Program for Young Adults With Fetal Alcohol Spectrum Disorders
NCT07016009
Tumor-Lymph Node Mapping
NCT07054944
A Pilot Randomized Controlled Trial of a Social Network Intervention
NCT07393529
Increasing Lung Cancer Screening Uptake Among Emergency Department Patients
NCT07287085
Advancing Lung Cancer Screening One Text at a Time
NCT07227480
Body Composition Related Evaluation of Airway Tone and Hyper-rEactivity Using Oscillometry
NCT07356310
Emergency Department-based Cervical Cancer Screening Through Self-sampling
NCT07345897
SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.
NCT06614322
Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories
NCT07263074
Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
NCT06956781
A Randomized Controlled Trial of Digital CBT to Treat Addiction: Digital RITch®CBT vs. Standard CBT
NCT05943171
Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer
NCT07630402
Visual Perception in Schizophrenia
NCT06911931
Mechanisms of Visual Restoration After Occipital Stroke
NCT07134777
Daridorexant to Prevent Post-cardiotomy Delirium
NCT07217912
Effect of Text Message Reminders on M-ISI Score After Prostate Surgery
NCT07071207
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator
NCT06964464
Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
NCT06260956
Auditory EEG and Behavioral Assessments in Individuals With Rett Syndrome
NCT07569445
Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer
NCT06295588
A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
NCT06697600
Digital Measures for Clinical Trial Endpoints in Huntington's Disease
NCT07010705
Actívatexto: Advancing Smoking Cessation and Physical Activity Among Latinos
NCT06926608
Dyadic Life Review Intervention for Older Patients With Advanced Cancer) and Their Caregivers
NCT06505122
The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
NCT06319872
My Health Coach App RCT
NCT06638463
Comparative Effectiveness of Prophylactic ICD Versus Non-ICD Therapy
NCT06543446
Incorporating Healthy Living Strategies to Aid in Recovery After Acute Pulmonary Embolism
NCT06784492
Chronic Kidney Disease-Education (CKD-EDU)
NCT06410144
Music for the Mind Study
NCT06866327
At-the-Breast vs. Expressed Human Milk: Genesis of Infant Nutrition (BEGIN)
NCT06691932
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
NCT06380114
Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy
NCT06473103
Cardiopulmonary Exercise Testing and Oscillometry for the Evaluation of Dyspnea
NCT06554353
Reducing Frailty for Older Cancer Survivors Using Supplements II
NCT06068543
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
NCT06313853
Intervening on Opioid Use and Loneliness
NCT06458335
Effect of Visual Retraining After Stroke
NCT06121219
Home Rehabilitation Improves Cardiac Effort in Pulmonary Arterial Hypertension
NCT06477640
Resilient Roots: Supporting Youth and Families
NCT06535516
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
NCT06369922
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
NCT06941389
A Telehealth Advance Care Planning Intervention
NCT05875805
Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax
NCT06262321
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rochester pipeline card: 636 registered trials from official public datasets.Report a data error.